日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Myeloma cell growth suppression by osteoblast-derived extracellular vesicles: the creation of a non-permissive niche for myeloma cells by bone-forming osteoblasts

成骨细胞来源的细胞外囊泡抑制骨髓瘤细胞生长：成骨细胞为骨髓瘤细胞创造一个不利的微环境

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.286554
Kim, SooHa; Teramachi, Jumpei; Hiasa, Masahiro; Amachi, Ryota; Bat-Erdene, Ariunzaya; Oda, Asuka; Tenshin, Hirofumi; Tanaka, Mariko; Nakagawa, Motosumi; Seki, Aiko; Sawa, Yoshihiko; Matsuoka, Ken-Ichi; Tanaka, Eiji; Harada, Takeshi; Tominaga, Tatsuya; Abe, Masahiro
囊泡
细胞生物学
骨髓瘤
发表日期：2025
文献求助 收藏

Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction

埃洛妥珠单抗介导的抗体依赖性细胞毒性作用（ADCC）可激活Th1样Vγ9Vδ2 T细胞，从而破坏骨髓瘤细胞与破骨细胞的相互作用。

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.16401
Inoue, Yusuke; Tenshin, Hirofumi; Teramachi, Jumpei; Sumitani, Ryohei; Oda, Asuka; Maeda, Yusaku; Oura, Masahiro; Sogabe, Kimiko; Maruhashi, Tomoko; Takahashi, Mamiko; Fujii, Shiro; Nakamura, Shingen; Miki, Hirokazu; Hara, Tomoyo; Endo, Itsuro; Kagawa, Kumiko; Ozaki, Shuji; Hiasa, Masahiro; Harada, Takeshi; Abe, Masahiro
DCC
T细胞
T细胞
骨髓瘤
细胞生物学
毒理研究
免疫/内分泌
发表日期：2025
文献求助 收藏

Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase

抑制HDAC1-IRF4轴和PIM激酶的新型抗骨髓瘤治疗方案

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2022007155
Harada, Takeshi; Ohguchi, Hiroto; Oda, Asuka; Nakao, Michiyasu; Teramachi, Jumpei; Hiasa, Masahiro; Sumitani, Ryohei; Oura, Masahiro; Sogabe, Kimiko; Maruhashi, Tomoko; Takahashi, Mamiko; Fujii, Shiro; Nakamura, Shingen; Miki, Hirokazu; Kagawa, Kumiko; Ozaki, Shuji; Sano, Shigeki; Hideshima, Teru; Abe, Masahiro
信号转导
骨髓瘤
HDAC1
发表日期：2023
文献求助 收藏

Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors

蛋白酶体抑制剂促进骨髓瘤骨病变中骨形成的机制

期刊:International Journal of Hematology
影响因子:1.8
doi:10.1007/s12185-023-03601-2
Nakaue, Emiko; Teramachi, Jumpei; Tenshin, Hirofumi; Hiasa, Masahiro; Harada, Takeshi; Oda, Asuka; Inoue, Yusuke; Shimizu, So; Higa, Yoshiki; Sogabe, Kimiko; Oura, Masahiro; Hara, Tomoyo; Sumitani, Ryohei; Maruhashi, Tomoko; Yamagami, Hiroki; Endo, Itsuro; Tanaka, Eiji; Abe, Masahiro
骨髓瘤
发表日期：2023
文献求助 收藏

Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphoma

间苯二酚内酯LL-Z1640-2治疗成人T细胞白血病/淋巴瘤的疗效

期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.758
Oura, Masahiro; Harada, Takeshi; Oda, Asuka; Teramachi, Jumpei; Nakayama, Atsushi; Sumitani, Ryohei; Inoue, Yusuke; Maeda, Yusaku; Sogabe, Kimiko; Maruhashi, Tomoko; Takahashi, Mamiko; Fujii, Shiro; Nakamura, Shingen; Miki, Hirokazu; Nakamura, Masafumi; Hara, Tomoyo; Yamagami, Hiroki; Kurahashi, Kiyoe; Endo, Itsuro; Hasegawa, Hiroo; Fujiwara, Hiroshi; Abe, Masahiro
T细胞
淋巴瘤
白血病
T细胞
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Mechanical unloading aggravates bone destruction and tumor expansion in myeloma

机械卸载会加剧骨髓瘤的骨破坏和肿瘤扩张。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2021.278295
Tanimoto, Kotaro; Hiasa, Masahiro; Tenshin, Hirofumi; Teramachi, Jumpei; Oda, Asuka; Harada, Takeshi; Higa, Yoshiki; Sogabe, Kimiko; Oura, Masahiro; Sumitani, Ryohei; Hara, Tomoyo; Endo, Itsuro; Matsumoto, Toshio; Tanaka, Eiji; Abe, Masahiro
肿瘤
肿瘤免疫
骨髓瘤
发表日期：2022
文献求助 收藏

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma

TAK1是骨髓瘤肿瘤进展和骨破坏的关键治疗靶点。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2019.234476
Teramachi, Jumpei; Tenshin, Hirofumi; Hiasa, Masahiro; Oda, Asuka; Bat-Erdene, Ariunzaya; Harada, Takeshi; Nakamura, Shingen; Ashtar, Mohannad; Shimizu, So; Iwasa, Masami; Sogabe, Kimiko; Oura, Masahiro; Fujii, Shiro; Kagawa, Kumiko; Miki, Hirokazu; Endo, Itsuro; Haneji, Tatsuji; Matsumoto, Toshio; Abe, Masahiro
肿瘤
肿瘤免疫
骨髓瘤
发表日期：2021
文献求助 收藏

Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma

Reveromycin A 是一种新型的嗜酸剂，可改善多发性骨髓瘤的骨破坏和肿瘤生长。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2019.244418
Watanabe, Keiichiro; Bat-Erdene, Ariunzaya; Tenshin, Hirofumi; Cui, Qu; Teramachi, Jumpei; Hiasa, Masahiro; Oda, Asuka; Harada, Takeshi; Miki, Hirokazu; Sogabe, Kimiko; Oura, Masahiro; Sumitani, Ryohei; Mitsui, Yukari; Endo, Itsuro; Tanaka, Eiji; Kawatani, Makoto; Osada, Hiroyuki; Matsumoto, Toshio; Abe, Masahiro
多发性骨髓瘤
肿瘤
肿瘤免疫
骨髓瘤
发表日期：2021
文献求助 收藏

Effective impairment of myeloma cells and their progenitors by hyperthermia.

热疗可有效抑制骨髓瘤细胞及其祖细胞

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.23121
Miki Hirokazu, Nakamura Shingen, Oda Asuka, Tenshin Hirofumi, Teramachi Jumpei, Hiasa Masahiro, Bat-Erdene Ariunzaya, Maeda Yusaku, Oura Masahiro, Takahashi Mamiko, Iwasa Masami, Harada Takeshi, Fujii Shiro, Kurahashi Kiyoe, Yoshida Sumiko, Kagawa Kumiko, Endo Itsuro, Aihara Kenichi, Ikuo Mariko, Itoh Kohji, Hayashi Koichiro, Nakamura Michihiro, Abe Masahiro
细胞生物学
发表日期：2018
文献求助 收藏

Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors.

与去岩藻糖基化的抗 HM1.24 单克隆抗体和来那度胺联合使用，可诱导针对骨髓瘤细胞及其祖细胞的显著 ADCC

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0083905
Harada Takeshi, Ozaki Shuji, Oda Asuka, Tsuji Daisuke, Ikegame Akishige, Iwasa Masami, Udaka Kengo, Fujii Shiro, Nakamura Shingen, Miki Hirokazu, Kagawa Kumiko, Kuroda Yoshiaki, Kawai Shigeto, Itoh Kohji, Yamada-Okabe Hisafumi, Matsumoto Toshio, Abe Masahiro
细胞生物学
发表日期：2013
文献求助 收藏